Pro Investor on eToro 🟢 Occasionally I swing trade & occasionally that works out 👀
My live tracker 👇
Joined August 2026
- Tweets4.3K
- Following147
- Followers1.1K
- Likes12.1K
Pinned Tweet
New here? Start with this 📌
I share free swing setups on US stocks, and every one goes on my public tracker:
mohanadinv.grok.me (also in my bio)
Every setup has a Confirm level, an Invalid level and up to 3 targets. The tracker follows each one from the day I post it.
What you can do there:
Filter by status: still valid, hit a target, exited or invalid
Filter by pattern: triangles, flags, wedges, cups, breakouts
Sort by newest, best close or highest peak
See the high each stock reached after I posted it
📊 Wins and losses stay up. Nothing gets deleted.
🟢 Average gain on winners: 20.1%
🔴 Average stop loss: down 6.2%
There's also an Investment ideas tab for my longer term plans.
Drop a ticker below and I'll check it for a pattern 👇
October 2026 is over. Tech took the hit 🌍 Here's how the world's markets did
$SPX S&P 500 down 0.9%
$NDX Nasdaq 100 down 6.7%
Kospi down 16.2%
Here's how every major market ended October 👇
🇮🇳 $SENSEX: up 2.7%
🇩🇪 $DAX: up 2.5%
🇺🇸 $DJI Dow: up 1.7%
🇬🇧 FTSE 100: up 1.2%
🇺🇸 $SPX S&P 500: down 0.9%
🇦🇪 DFM: down 3.2%
🇸🇦 Tadawul: down 5.0%
🇯🇵 Nikkei: down 5.2%
🇭🇰 Hang Seng: down 5.4%
🇨🇳 Shanghai: down 6.3%
🇺🇸 $NDX Nasdaq 100: down 6.7%
🇰🇷 Kospi: down 16.2%
Be honest: how much of your portfolio is tech right now?
The war is in its 8th month. Oil is above $100. $XOM and $CVX just hit record highs.
Most people are betting on one outcome. You must be ready for both 👇
🚨 If it escalates
$XOM record high this week
$CVX record high this week
$CRWD Iran hackers escalating
$JNJ healthcare doesn't stop for war
$AZN global pharma, steady demand
🕊️ If it ends
$AEM gold miners rallied on peace news
$SHW oil based costs ease
$PG oil cost hit fades
$DOV industrials led the ceasefire rebound
$EMR jumped on the ceasefire
Don't bet on the headline. Own both sides.
Which side are you on? 🤔
Cramer said buy 🚨🚨🚨
I just sold my stocks, my car, and the coffee in my hand ☕
Bear market officially sponsored by Jim Cramer 🐻
🤖 Made with AI
Mohanad Yaman retweeted
1 cent. That's what wiped about 31% off $ATEC premarket 📉😨
EPS $0.09 vs $0.10 expected
Sales $221M vs $225M expected
2026 sales guide cut to $862M
Surgery cases still grew 20%. Overreaction? 🤔
Mohanad Yaman retweeted
$LOW base breakout 👀
Lowe's, the US home improvement retailer selling to DIY and pro customers.
🔹 Ranged between $194.43 and $204.52 for 9 sessions (Oct 16 to Oct 28)
🔹 Yesterday it closed at $207.28, up 4.5%, over the top of the base at $204.52
📊 Q2 sales $26.0B (up 8.3%), comps up 0.2% for a 5th straight positive quarter, adjusted EPS $4.40 (up 1.6%, includes a $0.11 tariff refund benefit)
💰 2026 guide: sales about $92.0B, flat comps, adjusted EPS about $12.25, all at the low end of the prior ranges
📈 Pro, online (up 15.7%) and home services are carrying it while DIY spending stays soft
⚠️ Results come Nov 18 before the open, with the Street near $2.80 to $2.86 EPS vs $3.06 a year ago. Stifel cut its target from $220 to $195 on Oct 26 and kept a Hold
✅ Confirmed: daily close over $204.52
🟢 TP1 $221.67 (+8.4%) • TP2 $239.17 (+16.9%) • TP3 $254.04 (+24.2%)
⛔ Invalid: daily close under $201.45 (down 1.5%)
Risk from the $207.28 close to Invalid is about 2.8%, and TP1 pays about 2.5x.
Please respect your SL level 🙏
Mohanad Yaman retweeted
$IDCC descending triangle breakout 👀
InterDigital, licensor of the wireless, video and AI patents inside phones, PCs and streaming services.
🔹 Three lower highs at $355.69 (Sep 11), $346.80 (Oct 2) and $335.80 (Oct 21), with a flat base at $314.68 (Oct 15 low)
🔹 Yesterday it closed at $334.27, up 4.3% on earnings, over the falling line at $331.68
📊 Q3 revenue $193.4M (up 17%) vs its own guide of $154M to $158M, non-GAAP EPS $3.11 (up 22%) vs a guide of $1.94 to $2.13, record annualized recurring revenue of $629M
💰 2026 guide raised: revenue $813M to $819M, non-GAAP EPS $11.99 to $12.25, based only on contracts already signed
📈 New PC license through arbitration, 4 of the top 5 PC makers now licensed, dividend raised from $0.70 to $0.75
⚠️ Results are already out, so this is the post earnings move. $36.2M of Q3 revenue was one time catch up and smartphone revenue fell 10%. The close is only $2.59 over the confirm, and TP1 sits on the $355.69 September high. Next results expected around Feb 18
✅ Confirmed: daily close over $331.68
🟢 TP1 $355.69 (+7.2%) • TP2 $383.13 (+15.5%) • TP3 $421.23 (+27.0%)
⛔ Invalid: daily close under $326.70 (down 1.5%)
Risk from the $334.27 close to Invalid is about 2.3%, and TP1 pays about 2.8x.
Please respect your SL level 🙏
Mohanad Yaman retweeted
$ADMA base breakout 👀
ADMA, maker of plasma derived immune globulin drugs for people with weak immune systems.
🔹 Stuck under the $11.42 April high (Apr 24) for six months
🔹 Yesterday it closed at $11.75, up 4.2%, over that level at $11.42
📊 Q2 revenue $124.4M (up 2%), ASCENIV revenue $102.9M (up 24%), GAAP net income $37.8M (up 11%)
💰 2026 guide: revenue $530M to $560M, adjusted EBITDA $265M to $300M, reiterated in August
📈 ASCENIV is the growth driver, BIVIGAM demand is stabilizing after a 49% drop, and the company is buying back $200M or more of stock this year
⚠️ Results come Nov 4 after the close, with the Street at $0.20 EPS on $138M of revenue. That's about 11% above Q2 revenue, and it missed revenue estimates in both Q1 and Q2
✅ Confirmed: daily close over $11.42
🟢 TP1 $14.32 (+25.4%) • TP2 $16.39 (+43.5%) • TP3 $18.00 (+57.6%)
⛔ Invalid: daily close under $10.88 (down 4.7%)
Risk from the $11.75 close to Invalid is about 7.4%, and TP1 pays about 3.0x.
Please respect your SL level 🙏
Mohanad Yaman retweeted
Halloween came early this year 🎃
$RBLX down 16% premarket. Sales beat at $1.57B, but daily users 138M vs 146M expected
$TWLO down 20% premarket. EPS $1.65 beat, but Q4 growth guide slows to 11% to 12%
$ILMN down 14% premarket. EPS $1.44 beat, but sales $1.13B missed $1.15B
Beat earnings and still got spooked 👻
Mohanad Yaman retweeted
Answer: $REGN 💊
$REGN beat big. EPS $20.07 vs $16.07 est. Up 6.8% premarket.
$ABBV beat too and raised its 2026 guide, but it's down 2.9% premarket.
Both beat, so why is only one going up?
Mohanad Yaman retweeted
$XOM and $CVX both beat this morning 🛢️
$CVX: EPS $5.28 vs $4.89 est. Sales $67.8B vs $61.6B.
$XOM: EPS $4.23 vs $4.08 est. Sales $113.2B vs $103.1B.
High diesel prices did the work. Both ran their US refineries near full.
$XOM up 1.6% premarket, $CVX up 1.3%.
$XOM and $CVX are both up more than 50% this year. Both report this morning 🛢️
How they moved on the day of their last 4 reports:
$XOM
🔴 Oct 2025: down 0.3%
🟢 Jan 2026: up 0.6%
🔴 May 2026: down 1.0%
🔴 Jul 2026: down 1.0%
$CVX
🟢 Oct 2025: up 2.7%
🟢 Jan 2026: up 3.3%
🔴 May 2026: down 1.4%
🟢 Jul 2026: up 2.4%
Exxon barely moves. Chevron usually pops. What's your bet today? 👀
1 cent. That's what wiped about 31% off $ATEC premarket 📉😨
EPS $0.09 vs $0.10 expected
Sales $221M vs $225M expected
2026 sales guide cut to $862M
Surgery cases still grew 20%. Overreaction? 🤔
Halloween came early this year 🎃
$RBLX down 16% premarket. Sales beat at $1.57B, but daily users 138M vs 146M expected
$TWLO down 20% premarket. EPS $1.65 beat, but Q4 growth guide slows to 11% to 12%
$ILMN down 14% premarket. EPS $1.44 beat, but sales $1.13B missed $1.15B
Beat earnings and still got spooked 👻
$LOW base breakout 👀
Lowe's, the US home improvement retailer selling to DIY and pro customers.
🔹 Ranged between $194.43 and $204.52 for 9 sessions (Oct 16 to Oct 28)
🔹 Yesterday it closed at $207.28, up 4.5%, over the top of the base at $204.52
📊 Q2 sales $26.0B (up 8.3%), comps up 0.2% for a 5th straight positive quarter, adjusted EPS $4.40 (up 1.6%, includes a $0.11 tariff refund benefit)
💰 2026 guide: sales about $92.0B, flat comps, adjusted EPS about $12.25, all at the low end of the prior ranges
📈 Pro, online (up 15.7%) and home services are carrying it while DIY spending stays soft
⚠️ Results come Nov 18 before the open, with the Street near $2.80 to $2.86 EPS vs $3.06 a year ago. Stifel cut its target from $220 to $195 on Oct 26 and kept a Hold
✅ Confirmed: daily close over $204.52
🟢 TP1 $221.67 (+8.4%) • TP2 $239.17 (+16.9%) • TP3 $254.04 (+24.2%)
⛔ Invalid: daily close under $201.45 (down 1.5%)
Risk from the $207.28 close to Invalid is about 2.8%, and TP1 pays about 2.5x.
Please respect your SL level 🙏
$IDCC descending triangle breakout 👀
InterDigital, licensor of the wireless, video and AI patents inside phones, PCs and streaming services.
🔹 Three lower highs at $355.69 (Sep 11), $346.80 (Oct 2) and $335.80 (Oct 21), with a flat base at $314.68 (Oct 15 low)
🔹 Yesterday it closed at $334.27, up 4.3% on earnings, over the falling line at $331.68
📊 Q3 revenue $193.4M (up 17%) vs its own guide of $154M to $158M, non-GAAP EPS $3.11 (up 22%) vs a guide of $1.94 to $2.13, record annualized recurring revenue of $629M
💰 2026 guide raised: revenue $813M to $819M, non-GAAP EPS $11.99 to $12.25, based only on contracts already signed
📈 New PC license through arbitration, 4 of the top 5 PC makers now licensed, dividend raised from $0.70 to $0.75
⚠️ Results are already out, so this is the post earnings move. $36.2M of Q3 revenue was one time catch up and smartphone revenue fell 10%. The close is only $2.59 over the confirm, and TP1 sits on the $355.69 September high. Next results expected around Feb 18
✅ Confirmed: daily close over $331.68
🟢 TP1 $355.69 (+7.2%) • TP2 $383.13 (+15.5%) • TP3 $421.23 (+27.0%)
⛔ Invalid: daily close under $326.70 (down 1.5%)
Risk from the $334.27 close to Invalid is about 2.3%, and TP1 pays about 2.8x.
Please respect your SL level 🙏
$ADMA base breakout 👀
ADMA, maker of plasma derived immune globulin drugs for people with weak immune systems.
🔹 Stuck under the $11.42 April high (Apr 24) for six months
🔹 Yesterday it closed at $11.75, up 4.2%, over that level at $11.42
📊 Q2 revenue $124.4M (up 2%), ASCENIV revenue $102.9M (up 24%), GAAP net income $37.8M (up 11%)
💰 2026 guide: revenue $530M to $560M, adjusted EBITDA $265M to $300M, reiterated in August
📈 ASCENIV is the growth driver, BIVIGAM demand is stabilizing after a 49% drop, and the company is buying back $200M or more of stock this year
⚠️ Results come Nov 4 after the close, with the Street at $0.20 EPS on $138M of revenue. That's about 11% above Q2 revenue, and it missed revenue estimates in both Q1 and Q2
✅ Confirmed: daily close over $11.42
🟢 TP1 $14.32 (+25.4%) • TP2 $16.39 (+43.5%) • TP3 $18.00 (+57.6%)
⛔ Invalid: daily close under $10.88 (down 4.7%)
Risk from the $11.75 close to Invalid is about 7.4%, and TP1 pays about 3.0x.
Please respect your SL level 🙏
Answer: $REGN 💊
$REGN beat big. EPS $20.07 vs $16.07 est. Up 6.8% premarket.
$ABBV beat too and raised its 2026 guide, but it's down 2.9% premarket.
Both beat, so why is only one going up?
$XOM and $CVX both beat this morning 🛢️
$CVX: EPS $5.28 vs $4.89 est. Sales $67.8B vs $61.6B.
$XOM: EPS $4.23 vs $4.08 est. Sales $113.2B vs $103.1B.
High diesel prices did the work. Both ran their US refineries near full.
$XOM up 1.6% premarket, $CVX up 1.3%.
$XOM and $CVX are both up more than 50% this year. Both report this morning 🛢️
How they moved on the day of their last 4 reports:
$XOM
🔴 Oct 2025: down 0.3%
🟢 Jan 2026: up 0.6%
🔴 May 2026: down 1.0%
🔴 Jul 2026: down 1.0%
$CVX
🟢 Oct 2025: up 2.7%
🟢 Jan 2026: up 3.3%
🔴 May 2026: down 1.4%
🟢 Jul 2026: up 2.4%
Exxon barely moves. Chevron usually pops. What's your bet today? 👀